ClinicalTrials.gg
RecruitingNCT05168943Updated Sep 21, 2026

Nylon Versus Polyurethane Epidural Catheters In Patients Undergoing Major Orthopedic Surgery

An interventional study of Nylon (Polyamide) Epidural Catheter and Polyurethane Epidural Catheter in Epidural; Anesthesia, Catheter Complications and Catheter Blockage, sponsored by Damanhour Teaching Hospital. Recruiting at 1 site in Egypt. Open to participants aged 21 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by Damanhour Teaching Hospital · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
21 Years to 60 Years
Sex
All
01

Study summary

Objectives: To compare the safety and efficacy of nylon (polyamide) epidural catheter versus polyurethane epidural catheter in patients undergoing major orthopedic surgery under continuous epidural anesthesia.

Background: Continuous epidural anesthesia is the most common anesthetic technique used in orthopedic surgery. However, the use of epidural catheters is associated with complications. The insertion of the catheter may be associated with intravascular or intrathecal placement, nerve root irritation, paresthesia, kinking, hematoma, or breakage during catheter removal.

Patients and Methods: This was a prospective, randomized, double-blind clinical trial; carried out on 60 patients undergoing major orthopedic surgery under continuous epidural anesthesia. Patients were randomly allocated into two equal groups; group N, using Nylon catheter, and group P, using Polyurethane catheter.

02

Conditions studied

  • Epidural; Anesthesia
  • Catheter Complications
  • Catheter Blockage
  • Catheter Dysfunction
  • Catheter Breakage

Keywords

  • Epidural Anesthesia
  • Nylon (Polyamide) Epidural Catheter
  • Polyurethane Epidural Catheter
03

In context

Lead sponsor

Damanhour Teaching Hospital is the lead sponsor of 14 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • (ASA) physical status ≤ II
  • Age from 21 to 60 years
  • (BMI) \< 35

Exclusion criteria

Exclusion Criteria:

  • (ASA) physical status > II
  • Age \< 21 years or > 60 years
  • (BMI) ≥ 35
  • to regional anesthesia (including coagulopathy and infection at the injection site)
  • Uncooperative patients
  • Patients with known allergy to local anesthetics or opioids
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Group N (n=30)

    Continuous Epidural Anesthesia using Nylon (Polyamide) Epidural Catheter

    Device: Nylon (Polyamide) Epidural Catheter

  • Active comparator
    Group P (n=30)

    Continuous Epidural Anesthesia using Polyurethane Epidural Catheter

    Device: Polyurethane Epidural Catheter

Interventions

  • DeviceNylon (Polyamide) Epidural Catheter

    Nylon (Polyamide) Epidural Catheter

  • DevicePolyurethane Epidural Catheter

    Polyurethane Epidural Catheter

06

What researchers measure

Primary outcomes

  1. Mean and Standard deviation of Time required for epidural catheter insertion (seconds) (mean±SD)

    Time interval from holding the epidural catheter by the anesthetist till removal of the Tuohy needle through the epidural catheter by the anesthetist

    Time frame: 2 minutes after identifying the epidural space by loss of resistance technique

Secondary outcomes

  1. Mean and Standard deviation of Time required for epidural catheter to anchor with the catheter connector (seconds) (mean±SD)

    Time interval from holding the epidural catheter by the anesthetist till anchoring it with the catheter connector by the anesthetist

    Time frame: 2 minutes after removal of the Tuohy needle through the epidural catheter

  2. Mean and Standard deviation of Time required for epidural catheter removal (seconds) (mean±SD)

    Time interval from holding the epidural catheter by the anesthetist till removal of the epidural catheter by the anesthetist

    Time frame: 2 minutes after the end of the operation

  3. Number of participants and Rate of Catheter-related complications

    Number of participants and Rate of: Catheter kink, Catheter stretch, Difficult catheter insertion, Intravascular placement, Intrathecal placement, Paresthesia, Failure (asymmetric, unilateral, no block at 30 min), Hematoma, Breakage during removal.

    Time frame: 2 minutes after the end of the operation

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jul 2026 (actual). Primary completion is estimated for Dec 2027, 17 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 10, 2021
First posted
Dec 23, 2021
StartActual
Jul 1, 2026
Primary completionEst.
Dec 15, 2027
CompletionEst.
Dec 30, 2027
Last update
Sep 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05168943
Lead sponsor
Damanhour Teaching Hospital
Responsible party
Sponsor
First posted
Dec 23, 2021
Start date
Jul 1, 2026
Primary completion
Dec 15, 2027 (estimated)
Completion
Dec 30, 2027 (estimated)
Last update
Sep 21, 2026

Study contacts

Ahmed M Shaat, MD
Contact
ahmedshaat99@gmail.com
00201223482709
Ahmed M Shaat, MD
principal investigator · Damanhour Teaching Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion